Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014

authors:

avatar Farhood Nikouee 1 , avatar Mitra Soltanian 2 , avatar Alireza Safari 3 , avatar Mohadeseh Motamed-Jahromi 4 , *

Department of Community Medicine, Fasa University of Medical Sciences, Fasa, Iran
School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
Fasa University of Medical Sciences, Fasa, Iran
School of Nursing, Fasa University of Medical Sciences, Fasa, Iran

How To Cite Nikouee F, Soltanian M, Safari A, Motamed-Jahromi M. Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014. J Nurs Midwifery Sci. 2016;3(3):e141227. https://doi.org/10.18869/acadpub.jnms.3.3.40.

Abstract

Background and Purpose: Hepatitis B is a major health problem around the globe the prevalence of which varies depending on the
region and study. In this study, we aimed to determine the epidemiology and prevalence rates of hepatitis B in Fasa, Iran.
Methods: This descriptive, cross-sectional study was performed using medical records of all the hepatitis B patients referring to Fasa
Health Center during 2002-2014. The demographic variables and other required data were obtained and recorded, and then descriptive
statistics (frequency, mean, and percentage) were reported using SPSS, version 18.
Results: In this study, from the 208 patients, 83.2% were male, and 83.2% were aged between 21 and 30 years. The majority of the
hepatitis B patients (97.1%) did not have history of vaccination against the disease. The number of addicts using intravenous injection
and suffering from hepatitis B was higher (31.7%) than others. The prevalence rate of this disease was 0.01% in 2014.
Conclusion: The prevalence and incidence of hepatitis B in 2014 in Fasa indicate the necessity of prevention and vaccination for those
at high risk of the disease. Health education programs in schools, universities, organizations, and even mosques can play a major role
in preventing the prevalence of the disease.